Engineered Monoclonal Antibody with Novel Antigen-Sweeping Activity In Vivo
PLoS ONE, ISSN: 1932-6203, Vol: 8, Issue: 5, Page: e63236
2013
- 91Citations
- 143Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations91
- Citation Indexes77
- 77
- CrossRef65
- Patent Family Citations14
- Patent Families14
- Captures143
- Readers143
- 143
Article Description
Monoclonal antibodies are widely used to target disease-related antigens. However, because conventional antibody binds to the antigen but cannot eliminate the antigen from plasma, and rather increases the plasma antigen concentration by reducing the clearance of the antigen, some clinically important antigens are still difficult to target with monoclonal antibodies because of the huge dosages required. While conventional antibody can only bind to the antigen, some natural endocytic receptors not only bind to the ligands but also continuously eliminate them from plasma by pH-dependent dissociation of the ligands within the acidic endosome and subsequent receptor recycling to the cell surface. Here, we demonstrate that an engineered antibody, named sweeping antibody, having both pH-dependent antigen binding (to mimic the receptor-ligand interaction) and increased binding to cell surface neonatal Fc receptor (FcRn) at neutral pH (to mimic the cell-bound form of the receptor), selectively eliminated the antigen from plasma. With this novel antigen-sweeping activity, antibody without in vitro neutralizing activity exerted in vivo efficacy by directly eliminating the antigen from plasma. Moreover, conversion of conventional antibody with in vitro neutralizing activity into sweeping antibody further potentiated the in vivo efficacy. Depending on the binding affinity to FcRn at neutral pH, sweeping antibody reduced antigen concentration 50- to 1000-fold compared to conventional antibody. Thereby, sweeping antibody antagonized excess amounts of antigen in plasma against which conventional antibody was completely ineffective, and could afford marked reduction of dosage to a level that conventional antibody can never achieve. Thus, the novel mode of action of sweeping antibody provides potential advantages over conventional antibody and may allow access to the target antigens which were previously undruggable by conventional antibody. © 2013 Igawa et al.
Bibliographic Details
10.1371/journal.pone.0063236; 10.1371/journal.pone.0063236.g001; 10.1371/journal.pone.0063236.g002; 10.1371/journal.pone.0063236.g004; 10.1371/journal.pone.0063236.g005; 10.1371/journal.pone.0063236.g003; 10.1371/journal.pone.0063236.t001
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84877147797&origin=inward; http://dx.doi.org/10.1371/journal.pone.0063236; http://www.ncbi.nlm.nih.gov/pubmed/23667591; https://dx.plos.org/10.1371/journal.pone.0063236.g001; http://dx.doi.org/10.1371/journal.pone.0063236.g001; https://dx.plos.org/10.1371/journal.pone.0063236.g002; http://dx.doi.org/10.1371/journal.pone.0063236.g002; https://dx.plos.org/10.1371/journal.pone.0063236.g004; http://dx.doi.org/10.1371/journal.pone.0063236.g004; https://dx.plos.org/10.1371/journal.pone.0063236.g005; http://dx.doi.org/10.1371/journal.pone.0063236.g005; https://dx.plos.org/10.1371/journal.pone.0063236; https://dx.plos.org/10.1371/journal.pone.0063236.g003; http://dx.doi.org/10.1371/journal.pone.0063236.g003; https://dx.plos.org/10.1371/journal.pone.0063236.t001; http://dx.doi.org/10.1371/journal.pone.0063236.t001; https://dx.doi.org/10.1371/journal.pone.0063236.g001; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0063236.g001; https://dx.doi.org/10.1371/journal.pone.0063236.g003; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0063236.g003; https://dx.doi.org/10.1371/journal.pone.0063236.g004; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0063236.g004; https://dx.doi.org/10.1371/journal.pone.0063236.g002; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0063236.g002; https://dx.doi.org/10.1371/journal.pone.0063236.g005; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0063236.g005; https://dx.doi.org/10.1371/journal.pone.0063236.t001; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0063236.t001; https://dx.doi.org/10.1371/journal.pone.0063236; https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063236; http://dx.plos.org/10.1371/journal.pone.0063236.t001; http://dx.plos.org/10.1371/journal.pone.0063236; https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0063236&type=printable; http://dx.plos.org/10.1371/journal.pone.0063236.g003; http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0063236; http://dx.plos.org/10.1371/journal.pone.0063236.g001; http://www.plosone.org/article/metrics/info:doi/10.1371/journal.pone.0063236; http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0063236&type=printable; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063236; http://dx.plos.org/10.1371/journal.pone.0063236.g004; http://dx.plos.org/10.1371/journal.pone.0063236.g002; http://dx.plos.org/10.1371/journal.pone.0063236.g005
Public Library of Science (PLoS)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know